Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high likelihood of clinical efficacy.Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find cure of human cancer using its cutting edge TCR-T technologies. Using its p...
T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high likelihood of clinical efficacy.Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find cure of human cancer using its cutting edge TCR-T technologies. Using its proprietary iSORT TCR discovery platform, T-Cure expects to rapidly grow its pipeline of therapy candidates. The Company believes its TCR hold great promise in treating patients unaddressed by current modalities.

List your booth number for exhibitions, ask us